NR-533 Week 5 Discussion: Cost-Benefit Analysis
Week 5: Cost-Benefit Analysis
Consider and restate your PICO(T) and the proposal for your final project.
When you think of it as a type of new program development, what specific
information will you need to obtain to create the cost-benefit analysis as
part of your business plan for the project?
Hello class and DR. S.,
Healthcare cost increase in the last year of life due to high cost treatments. Advanced care
planning (ACP) can lead to cost reduction in end of life care mostly related to decrease
hospitalizations and high cost treatments and compliance with a person’s wishes. ACP can result
in higher quality of life at or near death, however, cost associated with discussion intervention
may lead to cost savings. (Nguyen et al., 2017)
My original PICOT question: In adults with a chronic life limiting non-cancerous illness, how
does end of life discussions in comparison to no discussions affect the completion of an
advanced care plan/advanced directive over a 4-6 weeks evaluation period?
P-atient-Adults with a chronic life limiting non-cancerous illness
I-ntervention-End of life discussions
C-omparison-Adults without a chronic life limiting non-cancerous illness
O-utcome-Completion of ACP/Advanced directive
T-ime-4-6 weeks
Cost associated with any new program needs to be projected in the business plan. This would
be considered a new program/service. Specific information needed to create a cost-benefit
analysis include: patient volume, revenue per patent, variable cost, fixed cost, projected visits
per year, and days of operation. However, there is limited studies indicating there is a cost
benefit related to this intervention. Cost reduction and savings is associated with decreased
treatment and acute care hospital admission in the last year of life. (Aldridge & Kelley, 2015)
Gwen
Aldridge, M. D., & Kelley, A. S. (2015). The Myth Regarding the High Cost of End-of-Life
Care. American Journal of Public Health, 105(12), 2411–2415.
https://doi.org/10.2105/ajph.2015.302889
Nguyen, K.-H., Sellars, M., Agar, M., Kurrle, S., Kelly, A., & Comans, T. (2017). An economic
model of advance care planning in Australia: a cost-effective way to respect patient choice.
BMC Health Services Research, 17(1). https://doi.org/10.1186/s12913-017-2748-4
This study source was downloaded by 100000801755870 from CourseHero.com on 03 -24-2022 05:27:31 GMT -05:00
https://www.coursehero.com/file/76578630/Week-5Discussion-Cost-Benefit-Analysisdocx/
Week 5: Cost-Benefit Analysis
Consider and restate your PICO(T) and the proposal for your final project.
When you think of it as a type of new program development, what specific
information will you need to obtain to create the cost-benefit analysis as
part of your business plan for the project?
Hello class and DR. S.,
Healthcare cost increase in the last year of life due to high cost treatments. Advanced care
planning (ACP) can lead to cost reduction in end of life care mostly related to decrease
hospitalizations and high cost treatments and compliance with a person’s wishes. ACP can result
in higher quality of life at or near death, however, cost associated with discussion intervention
may lead to cost savings. (Nguyen et al., 2017)
My original PICOT question: In adults with a chronic life limiting non-cancerous illness, how
does end of life discussions in comparison to no discussions affect the completion of an
advanced care plan/advanced directive over a 4-6 weeks evaluation period?
P-atient-Adults with a chronic life limiting non-cancerous illness
I-ntervention-End of life discussions
C-omparison-Adults without a chronic life limiting non-cancerous illness
O-utcome-Completion of ACP/Advanced directive
T-ime-4-6 weeks
Cost associated with any new program needs to be projected in the business plan. This would
be considered a new program/service. Specific information needed to create a cost-benefit
analysis include: patient volume, revenue per patent, variable cost, fixed cost, projected visits
per year, and days of operation. However, there is limited studies indicating there is a cost
benefit related to this intervention. Cost reduction and savings is associated with decreased
treatment and acute care hospital admission in the last year of life. (Aldridge & Kelley, 2015)
Gwen
Aldridge, M. D., & Kelley, A. S. (2015). The Myth Regarding the High Cost of End-of-Life
Care. American Journal of Public Health, 105(12), 2411–2415.
https://doi.org/10.2105/ajph.2015.302889
Nguyen, K.-H., Sellars, M., Agar, M., Kurrle, S., Kelly, A., & Comans, T. (2017). An economic
model of advance care planning in Australia: a cost-effective way to respect patient choice.
BMC Health Services Research, 17(1). https://doi.org/10.1186/s12913-017-2748-4
This study source was downloaded by 100000801755870 from CourseHero.com on 03 -24-2022 05:27:31 GMT -05:00
https://www.coursehero.com/file/76578630/Week-5Discussion-Cost-Benefit-Analysisdocx/
